These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 769882)

  • 1. Proceedings: gamma-Aminobutyric acid metabolism and the anticonvulsant action of ethanolamine-o-sulphate and di-n-propylacetate.
    Anlezark GM; Horton RW; Meldrum BS; Sawaya MC; Stephenson JD
    Br J Pharmacol; 1976 Mar; 56(3):383P-384P. PubMed ID: 769882
    [No Abstract]   [Full Text] [Related]  

  • 2. Anticonvulsant action of ethanolamine-O-sulphate and di-n-propylacetate and the metabolism of gamma-aminobutyric acid (GABA) in mice with audiogenic seizures.
    Anlezark G; Horton RW; Meldrium BS; Sawaya CB
    Biochem Pharmacol; 1976 Feb; 25(4):413-7. PubMed ID: 779794
    [No Abstract]   [Full Text] [Related]  

  • 3. Monoamine and GABA metabolism and the anticonvulsant action of di-n-propylacetate and ethanolamine-O-sulphate.
    Horton RW; Anlezark GM; Sawaya MC; Meldrum BS
    Eur J Pharmacol; 1977 Feb; 41(4):387-97. PubMed ID: 139317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Time course of the increase in GABA level in different mice brain regions following N-dipropylacetate treatment.
    Simler S; Gensburger C; Ciesielski L; Mandel P
    Commun Psychopharmacol; 1978; 2(2):123-30. PubMed ID: 352606
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of sodium valproate and ethanolamine-o-sulphate on GABA metabolism in vivo [proceedings].
    Taberner PV
    Br J Pharmacol; 1979 Nov; 67(3):441P. PubMed ID: 387149
    [No Abstract]   [Full Text] [Related]  

  • 6. [On the mechanism of action of valproid acid].
    Löscher W; Frey HH
    Arzneimittelforschung; 1977; 27(5):1081-2. PubMed ID: 328017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of sodium n-dipropylacetate on the GABA level in various areas of the mouse brain].
    Simler S; Gensburger C; Ciesielski L; Mandel P
    C R Seances Soc Biol Fil; 1976; 170(6):1285-8. PubMed ID: 140750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Di-n-propylacetic acid--profile of anticonvulsant activity in mice.
    Frey HH; Löscher W
    Arzneimittelforschung; 1976 Feb; 26(2):299-301. PubMed ID: 779804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of anticonvulsant drugs on brain amino acid metabolism.
    Chapman AG; Meldrum BS
    Prog Clin Biol Res; 1983; 124():63-76. PubMed ID: 6410409
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessment of the anticonvulsant activity of inhibitors of high-affinity GABA uptake [proceedings].
    Roberts F; Taberner PV
    Br J Pharmacol; 1977 Nov; 61(3):476P. PubMed ID: 588826
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of di-n-propylacetate on the 'binding of GABA to synaptosome-enriched fraction of rat cerebral cortex.
    Kulig BM; Gonzalez-Portal C; Somoza E; Defeudis FV
    Psychopharmacology (Berl); 1977 Aug; 53(3):255-7. PubMed ID: 408853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of di-n-propylacetate, gabaculine, and aminooxyacetic acid: anticonvulsant activity and the gamma-aminobutyrate system.
    Wood JD; Kurylo E; Tsui SK
    J Neurochem; 1981 Dec; 37(6):1440-7. PubMed ID: 6801201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproic acid: brain and plasma levels of the drug and its metabolites, anticonvulsant effects and gamma-aminobutyric acid (GABA) metabolism in the mouse.
    Nau H; Löscher W
    J Pharmacol Exp Ther; 1982 Mar; 220(3):654-9. PubMed ID: 6801254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Failure of increased brain gamma-aminobutyric acid levels to influence amphetamine-induced stereotyped behavior.
    Patel BC; Crosset P; Klawans HL
    Res Commun Chem Pathol Pharmacol; 1975 Dec; 12(4):635-43. PubMed ID: 766131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neurochemical aspects and pharmacological implications in essential tremor (preliminary note)].
    Piccoli F; Smorto MP; Raimondo D; Fierro B; Vinci GG; Lupo I; Pastore L; Daniele O
    Acta Neurol (Napoli); 1977; 32(4):473-80. PubMed ID: 333871
    [No Abstract]   [Full Text] [Related]  

  • 16. The behavioural effects of EOS-induced changes in substantia nigra GABA levels [proceedings].
    Koob G; del Fiacco M; Iversen SD
    Br J Pharmacol; 1976 Nov; 58(3):454P. PubMed ID: 990632
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of valproic acid on levels of GABA and glutamic acid in pentylenetetrazole-damaged rat brain.
    Calderón Guzmán D; Espitia Vázquez I; Barragán Mejía G; Labra Ruiz N; Rodríguez Pérez R; Santamaria del Angel D; Ayala Guerrero F; Juárez Olguín H
    Proc West Pharmacol Soc; 2003; 46():48-50. PubMed ID: 14699883
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of intravenous administration of gamma-hydroxybutyric and succinic acids on the metabolism of gamma-aminobutyric acid in the brain].
    Promyslov MSh; Solov'eva TV
    Vopr Med Khim; 1973; 19(4):401-3. PubMed ID: 4153200
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of sodium valproate on gamma-aminobutyrate metabolism and behaviour in naive and ethanolamine-O-sulphate pretreated rats and mice.
    Phillips NI; Fowler LJ
    Biochem Pharmacol; 1982 Jul; 31(13):2257-61. PubMed ID: 6812585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute anticonvulsant activity of structural analogues of valproic acid and changes in brain GABA and aspartate content.
    Chapman AG; Meldrum BS; Mendes E
    Life Sci; 1983 Apr; 32(17):2023-31. PubMed ID: 6403794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.